In The News
This week, the American Association for Cancer Research (AACR) released its AACR Cancer Disparities Progress Report 2022. According to the report, while overall cancer incidence and mortality rates are declining across all groups, disparities across the cancer continuum remain a public health challenge. The report cites the need for more funding, increased representation of patients from different […]
A new research study showed that circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of treatment. This research was supported by the Lustgarten Foundation, Australian […]
The team says it will focus on a mutated gene found in over 90% of pancreatic cancers. They say targeting that gene will be the best way to improve treatment.
Lustgarten was founded on the principle that funding innovative, cutting-edge research is the only way to improve patient outcomes and ultimately turn pancreatic cancer into a curable disease. Dr. Joseph Herman, Vice Chair of Clinical Informatics for Radiation Medicine and Director of Clinical Research Integration at Northwell Health, joined Lustgarten’s Vice President of Research, Dr. Andrew Rakeman, […]
In recognition of Mother’s Day, and in honor of Barbara, Stephanie and all women impacted by pancreatic cancer, please give your most generous gift today. Now through midnight on Mother’s Day—Sunday, May 9—your donation will be matched 5x up to $35,000*, thanks to Stephanie Kessler and Laura Hull, who also lost her mom to pancreatic cancer. That means […]